Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of Thiazolidinediones

Dutchak, Paul A., Katafuchi, Takeshi, Bookout, Angie L., Choi, Jang Hyun, Yu, Ruth T., Mangelsdorf, David J., Kliewer, Steven A.·2012·Cell
DOI 10.1016/j.cell.2011.11.062

Cited by (538)

Items 101–200 of 538

  1. The FGF21–adiponectin axis in controlling energy and vascular homeostasis
    Xiaoyan Hannah Hui, Tianshi Feng, Qing Liu, Yuan Gao, Aimin Xu · 2016 · Journal of Molecular Cell Biology
  2. An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function.
    Ju Hee Lee, Yea Eun Kang, Joon Young Chang, Ki Cheol Park, Hyeon-Woo Kim, Jung Tae Kim, Hyun Jin Kim, Hyon‐Seung Yi, Minho Shong, Hyo Kyun Chung et al. · 2016 · PubMed Central
  3. Retinoic Acid Receptor β Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice
    Yu Li, Kimberly Wong, Kenneth Walsh, Bin Gao, Mengwei Zang · 2013 · Journal of Biological Chemistry
  4. Glyoxalase 1 Modulation in Obesity and Diabetes
    Rabbani, Naila, Thornalley, Paul J. · 2019 · Antioxidants & Redox Signaling
  5. Fibroblast growth factor 21 night watch: advances and uncertainties in the field
    Alexei Kharitonenkov, Richard D. DiMarchi · 2016 · Journal of Internal Medicine
  6. Obesity: An Immunometabolic Perspective
    Indrani Ray, Sushil Kumar Mahata, Rajat Kumar De · 2016 · Frontiers in Endocrinology
  7. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers
    Yan Leng, Zheng Wang, L-K Tsai, Peter R. Leeds, Emily Bame Fessler, J Wang, D M Chuang · 2014 · Molecular Psychiatry
  8. A long‐acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non‐alcoholic steatohepatitis partly through an FGF21‐adiponectin‐IL17A pathway
    Lichen Bao, Jun Yin, Wen Gao, Qun Wang, W. Yao, Xiang-Dong Gao · 2018 · British Journal of Pharmacology
  9. Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling
    Suocheng Hui, Yang Liu, Li Huang, Lin Zheng, Min Zhou, Hedong Lang, Xiaolan Wang, Long Yi, Mantian Mi · 2020 · International Journal of Obesity
  10. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
    Emma Henriksson, Birgitte Andersen · 2020 · Frontiers in Endocrinology
  11. Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
    Claudia Cicione, Chiara Degirolamo, Antonio Moschetta · 2012 · Hepatology
  12. Hepatokines as a Link between Obesity and Cardiovascular Diseases
    Hye Jin Yoo, Kyung Mook Choi · 2015 · Diabetes & Metabolism Journal
  13. The Role of PPARγ in Cardiovascular Diseases
    Miroslava Kvandová, Miroslava Majzúnová, Ima Dovinová · 2016 · Physiological Research
  14. Dyslipidemia in retinal metabolic disorders
    Zhongjie Fu, Chuck T. Chen, Gaël Cagnone, Émilie Heckel, Ye Sun, Bertan Cakir, Yohei Tomita, Shuo Huang, Qian Li, William R. Britton et al. · 2019 · EMBO Molecular Medicine
  15. Targeting FGF21 for the Treatment of Nonalcoholic Steatohepatitis
    Mohammad Zarei, Javier Pizarro‐Delgado, Emma Barroso, Xavier Palomer, Manuel Vázquez‐Carrera · 2020 · Trends in Pharmacological Sciences
  16. Adipokines and the Endocrine Role of Adipose Tissues
    Marta Giralt, Rubén Cereijo, Francesc Villarroya · 2015 · Handbook of experimental pharmacology
  17. Brown adipose tissue: Updates in cellular and molecular biology
    Thereza Cristina Lonzetti Bargut, Márcia Barbosa Águila, Carlos Alberto Mandarim‐de‐Lacerda · 2016 · Tissue and Cell
  18. Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue
    Elayne Hondares, José Miguel Gallego-Escuredo, Pavel Flachs, Andrea Frontini, Rubén Cereijo, Albert Goday, Jessica Perugini, Pavel Kopecky, Marta Giralt, Saverio Cinti et al. · 2013 · Metabolism
  19. The Impact of Moderate-Intensity Continuous or High-Intensity Interval Training on Adipogenesis and Browning of Subcutaneous Adipose Tissue in Obese Male Rats
    Mousa Khalafi, Hamid Mohebbi, Michael Edward Symonds, Pouran Karimi, Amir Mahdi Akbari, Elma Tabari, Mehrsa Faridnia, Kamilia Moghaddami · 2020 · Nutrients
  20. Knockdown of PU.1 AS lncRNA inhibits adipogenesis through enhancing PU.1 mRNA translation
    Wei-Jun Pang, Ligen Lin, Yan Xiong, Ning Wei, Yu Wang, Qingwu W. Shen, Gong-She Yang · 2013 · Journal of Cellular Biochemistry
  21. Signaling pathways and intervention for therapy of type 2 diabetes mellitus
    Rong Yue Cao, Huimin Tian, Yu Zhang, Geng Liu, Haixia Xu, Guocheng Rao, Yan Tian, Xianghui Fu · 2023 · MedComm
  22. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
    Wing Yan So, Po Sing Leung · 2016 · Medicinal Research Reviews
  23. Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
    Xiang Zhang, Harry Cheuk-Hay Lau, Jun Qing Yu · 2025 · Pharmacological Reviews
  24. Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes
    Kwok Leung Ong, Kerry‐Anne Rye, Rachel L O'Connell, Alicia Josephine Jenkins, Chris S. B. Brown, Aimin Xu, DAVID R. SULLIVAN, Philip J. Barter, ANTHONY C. KEECH, on behalf of the FIELD study investigators · 2012 · The Journal of Clinical Endocrinology & Metabolism
  25. The global perspective on peroxisome proliferator-activated receptor γ (PPARγ) in ectopic fat deposition: A review
    Yanhao Qiu, Mailin Gan, Xingyu Wang, Tianci Liao, Qiuyang Chen, Yuhang Lei, Lei Chen, Jinyong Wang, Ye Zhao, Lili Niu et al. · 2023 · International Journal of Biological Macromolecules
  26. S-nitrosoglutathione reductase–dependent PPARγ denitrosylation participates in MSC-derived adipogenesis and osteogenesis
    Yenong Cao, Samirah Abreu Gomes, Érika Bevilaqua Rangel, Ellena C. Paulino, Tatiana L. Fonseca, Jinliang Li, Marilia Bianca Cruz Grecco Teixeira, Cecília Helena de Azevedo Gouveia, Antonio Carlos Bianco, Michael S. Kapiloff et al. · 2015 · Journal of Clinical Investigation
  27. Nuclear Mechanisms of Insulin Resistance
    Sona Kang, Linus T.-Y. Tsai, Evan D. Rosen · 2016 · Trends in Cell Biology
  28. Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes
    William B. Horton, Kaitlin M. Love, Justin M. Gregory, Zhenqi Liu, Eugene J. Barrett · 2025 · American Journal of Physiology-Heart and Circulatory Physiology
  29. Controlling a master switch of adipocyte development and insulin sensitivity: Covalent modifications of PPARγ
    Z. Elizabeth Floyd, Jacqueline M. Stephens · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  30. Bone marrow adipose tissue: formation, function and regulation
    Karla J. Suchacki, William Peter Cawthorn, Clifford james Rosen · 2016 · Current Opinion in Pharmacology
  31. Obesity as the common soil of non‐alcoholic fatty liver disease and diabetes: Role of adipokines
    Elaine Hui, Aimin Xu, Hong Bo Yang, Karen S.L. Lam · 2013 · Journal of Diabetes Investigation
  32. Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury
    Liu, Yanlong, Zhao, Cuiqing, Xiao, Jian, Liu, Liming, Zhang, Min, Wang, Cuiling, Wu, Guicheng, Zheng, Ming-Hua, Xu, Lan-Man, Chen, Yong-Ping et al. · 2016 · Scientific Reports
  33. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice
    Wing Yan So, Qi Cheng, Aimin Xu, Karen S.L. Lam, Po Sing Leung · 2015 · Cell Death and Disease
  34. Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysis
    Ishan Lakhani, Mengqi Gong, Wing Tak Wong, George Bazoukis, Konstantinos M Lampropoulos, Sunny Hei Wong, William Ka Kei Wu, Martin C. S. Wong, Kwok Leung Ong, Tong Liu et al. · 2018 · Metabolism
  35. Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
    Andrew Charles Adams, Tamer Coşkun, Christine Cheng, Libbey S. O’Farrell, Susan L. DuBois, Alexei Kharitonenkov · 2013 · Molecular Metabolism
  36. SIK2 Is Critical in the Regulation of Lipid Homeostasis and Adipogenesis In Vivo
    Jinyoung Park, Young-Sil Yoon, Hye-Sook Han, Yong‐Hoon Kim, Yoshihiro Ogawa, Keun‐Gyu Park, Chul‐Ho Lee, Seong‐Tae Kim, Seung‐Hoi Koo · 2014 · Diabetes
  37. Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome
    Jun Zhang, Yang Li · 2013 · Drug Discovery Today
  38. PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine
    Simona Cataldi, Valerio Costa, Alfredo Ciccodicola, Marianna Aprile · 2021 · Current Diabetes Reports
  39. The potential function and clinical application of FGF21 in metabolic diseases
    Zhiwei Chen, Lili Yang, Yang Liu, Ping Huang, Haiyan Song, Peiyong Zheng · 2022 · Frontiers in Pharmacology
  40. Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism
    Hiroya Ohta, Nobuyuki Itoh · 2014 · Frontiers in Endocrinology
  41. The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension
    Zhe Ping Huang, Aimin Xu, Bernard M.Y. Cheung · 2017 · Current Hypertension Reports
  42. Fibroblast Growth Factor 21 Protects Photoreceptor Function in Type 1 Diabetic Mice
    Zhongjie Fu, Zhongxiao Wang, Chi‐Hsiu Liu, Yan Qing Gong, Bertan Cakir, Raffael Gi-Hwan Liegl, Ye Sun, Steven S. Meng, Samuel B. Burnim, Ivana A. Arellano et al. · 2018 · Diabetes
  43. Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway
    Tong Wu, Qinhui Liu, Yanping Li, Hong Li, Lei Chen, Xuping Yang, Qin Tang, Shiyun Pu, Jiangying Kuang, Rui Li et al. · 2021 · The Journal of Experimental Medicine
  44. Implication of hepatokines in metabolic disorders and cardiovascular diseases
    Jung, Tae Woo, Yoo, Hye Jin, Choi, Kyung Mook · 2016 · BBA Clinical
  45. Dual actions of fibroblast growth factor 19 on lipid metabolism
    Xinle Wu, Hongfei Ge, Hélène Baribault, Jamila Gupte, Jennifer Weiszmann, Bryan D. Lemon, Jonitha Gardner, Preston Fordstrom, Jie Tang, Mingyue Zhou et al. · 2012 · Journal of Lipid Research
  46. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity
    Nasim Babaknejad, Hashem Nayeri, Roohullah Hemmati, Somaye Bahrami, Ahmad Esmaillzadeh · 2018 · Hormone and Metabolic Research
  47. Brown and Brite: The Fat Soldiers in the Anti-obesity Fight
    Shireesh Srivastava, Richard L. Veech · 2019 · Frontiers in Physiology
  48. Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
    Nicole Aaron, Michael James Kraakman, Qiuzhong Zhou, Qiongming Liu, Samantha Costa, Jing Liang Yang, Longhua Liu, Lexiang Yu, Liheng Wang, Ying He et al. · 2021 · eLife
  49. Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
    Jun Zhang, Yang Li · 2015 · Frontiers in Endocrinology
  50. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice
    Tsuyoshi Goto, Mariko Hirata, Yumeko Aoki, Mari Iwase, Haruya Takahashi, Minji Kim, Yongjia Li, Huei‐Fen Jheng, Wataru Nomura, Nobuyuki Takahashi et al. · 2017 · Journal of Biological Chemistry
  51. Aging and lineage allocation changes of bone marrow skeletal (stromal) stem cells
    Jan Olof Nehlin, Abbas Jafari, Michaela Tencerová, Moustapha S Kassem · 2019 · Bone
  52. Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPARγ) agonist with potent glucose-lowering properties
    Christopher Weidner, Sylvia J. Wowro, Anja Freiwald, K. Kawamoto, A. Witzke, Magdalena Kliem, Karsten Siems, Lutz Müller‐Kuhrt, Frank C. Schroeder, Sascha Sauer · 2013 · Diabetologia
  53. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta)
    Else Nygaard, Cathrine Laustrup Møller, Paul Kievit, Kevin L. Grove, B Andersen · 2013 · International Journal of Obesity
  54. Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology
    Huating Li, Jing Zhang, Weiping Jia · 2013 · Frontiers of Medicine
  55. The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis
    James Cantley · 2014 · Mammalian Genome
  56. The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation
    Nicole Witte, Matthias Muenzner, Janita Rietscher, Miriam Knauer, Steffi Heidenreich, Alli M. Nuotio-Antar, Franziska A. Graef, Ronja Fedders, Alexander Tolkachov, Isabel Göhring et al. · 2015 · Endocrinology
  57. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis
    You-Ying Chau, Nicholas Dixon Hastie · 2012 · Trends in Genetics
  58. Potential roles of fibroblast growth factor 21 in the brain
    Piangkwan Sa‐nguanmoo, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2016 · Metabolic Brain Disease
  59. FGF21 Protects against Aggravated Blood-Brain Barrier Disruption after Ischemic Focal Stroke in Diabetic db/db Male Mice via Cerebrovascular PPARγ Activation
    Yinghua Jiang, Li Lin, Ning Liu, Qingzhi Wang, Jing Yuan, Yadan Li, Kelly K. Chung, Shuzhen Guo, Zhanyang Yu, Xiaoying Wang · 2020 · International Journal of Molecular Sciences
  60. The role of fibroblast growth factor 21 in atherosclerosis
    John Kokkinos, Shudi Tang, Kerry‐Anne Rye, Kwok Leung Ong · 2016 · Atherosclerosis
  61. Calorie restriction and Roux‐en‐Y gastric bypass have opposing effects on circulating FGF 21 in morbidly obese subjects
    Mirjam A. Lips, Gerrit H. de Groot, Frits J. Berends, Marinus J. Wiezer, Bart A. van Wagensveld, Dingeman J. Swank, Arijan A. P. M. Luijten, Ko Willems van Dijk, Hanno Pijl, Peter L. M. Jansen et al. · 2014 · Clinical Endocrinology
  62. Current concepts in the pathogenesis of traumatic temporomandibular joint ankylosis
    Ying‐Bin Yan, Su-Xia Liang, Jun Shen, Jian-cheng Zhang, Yi Zhang · 2014 · Head & Face Medicine
  63. FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
    Kook Hwan Kim, Myung‐Shik Lee · 2015 · Journal of Endocrinology
  64. Metformin Stimulates FGF21 Expression in Primary Hepatocytes
    Eva B. Nygaard, Sara G. Vienberg, Cathrine Ørskov, Harald Severin Hansen, Birgitte Andersen · 2012 · Experimental Diabetes Research
  65. Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues
    Xiaolong Lin, Yuan Bo Liu, Huijun Hu · 2017 · Biomedical Reports
  66. Gamma-Aminobutyric Acid Signaling in Damage Response, Metabolism, and Disease
    Kimyeong Kim, Haejin Yoon · 2023 · International Journal of Molecular Sciences
  67. Skeletal muscle‐specific eukaryotic translation initiation factor 2α phosphorylation controls amino acid metabolism and fibroblast growth factor 21‐mediated non‐cell‐autonomous energy metabolism
    Masato Miyake, Akitoshi Nomura, Atsushi Ogura, Kenji Takehana, Yoshihiro Kitahara, Kazuna Takahara, Kazue Tsugawa, Chinobu Miyamoto, Naoko Miura, Ryosuke Sato et al. · 2015 · The FASEB Journal
  68. Nrf2 induces fibroblast growth factor 21 in diabetic mice
    Yuki Furusawa, Akira Uruno, Yoko Yagishita, Chika Higashi, Masayuki P. Yamamoto · 2014 · Genes to Cells
  69. Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice
    Mingming Gao, Le Bu, Yongjie Ma, Dexi Liu · 2013 · PLoS ONE
  70. Lactate induces FGF21 expression in adipocytes through a p38-MAPK pathway
    Yannick Jeanson, Francesc Ribas‐Aulinas, Anne Galinier, Emmanuelle Arnaud, Marion Ducos, Mireille André, Vanessa Chenouard, Francesc Villarroya, Louis Casteilla, Audrey Carrière · 2016 · Biochemical Journal
  71. FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
    Li, Xiaodong, Stanislaus, Shanaka, Asuncion, Frank, Niu, Qing-Tian, Chinookoswong, Narumol, Villasenor, Kelly, Wang, Jin, Wong, Philip, Boyce, Rogely, Dwyer, Denise et al. · 2017 · Journal of Bone and Mineral Research
  72. Sex Differences in Liver, Adipose Tissue, and Muscle Transcriptional Response to Fasting and Refeeding in Mice
    Н. М. Бажан, Tatiana Jakovleva, Natalia A. Feofanova, E. I. Denisova, Anastasia Dubinina, Natalia Sitnikova, Makarova En · 2019 · Cells
  73. PPARγ deacetylation dissociates thiazolidinedione’s metabolic benefits from its adverse effects
    Michael James Kraakman, Qiongming Liu, Jorge Postigo-Fernandez, Ruiping Ji, Ning Kon, Delfina Larrea, Maria Namwanje, Lihong Fan, Michelle Chan, Estela Área-Gómez et al. · 2018 · Journal of Clinical Investigation
  74. Regulation of adipocyte thermogenesis: mechanisms controlling obesity
    Mohammed Faiz Hussain, Anna A. Roesler, Lawrence Kazak · 2020 · FEBS Journal
  75. The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective
    Jianjun Liu, Joo Pin Foo, Sylvia Liu, Su Chi Lim · 2015 · Diabetes Research and Clinical Practice
  76. Fibroblast Growth Factor 21 Protects Against High Glucose Induced Cellular Damage and Dysfunction of Endothelial Nitric-Oxide Synthase in Endothelial Cells
    Xiaomei Wang, Shuang‐Shuang Song, Hang Xiao, Pan Gao, Xue-Jun Li, Liangyi Si · 2014 · Cellular Physiology and Biochemistry
  77. Clinical Implications of Adipocytokines and Newly Emerging Metabolic Factors with Relation to Insulin Resistance and Cardiovascular Health
    Sung Hee Choi, Eun Shil Hong, Soo Kyung Lim · 2013 · Frontiers in Endocrinology
  78. Sex differences in the development of hepatic steatosis in cafeteria diet-induced obesity in young mice
    Fabiana Rodrigues Silva Gasparin, Fernando Olinto Carreño, Juliana Moraes Mewes, Eduardo Hideo Gilglioni, Clairce Luzia Salgueiro Pagadigorria, Maria Raquel Marçal Natali, Karina Sayuri Utsunomiya, Rodrigo Polimeni Constantin, Amanda Tomie Ouchida, Carlos Curti et al. · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  79. Downstream Signaling Pathways in Mouse Adipose Tissues Following Acute In Vivo Administration of Fibroblast Growth Factor 21
    Muise, Eric S., Souza, Sandra, Chi, An, Tan, Yejun, Zhao, Xuemei, Liu, Franklin, Dallas-yang, Qing, Wu, Margaret, Sarr, Tim, Zhu, Lan et al. · 2013 · PLoS ONE
  80. Increased Placental Expression of Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus
    Marloes Dekker Nitert, Helen L. Barrett, Marta Helena Kubala, Katherin Scholz‐Romero, Kerina J. Denny, Trent M. Woodruff, David H. McIntyre, Leonie Kaye Callaway · 2014 · The Journal of Clinical Endocrinology & Metabolism
  81. Fat Wasting Is Damaging: Role of Adipose Tissue in Cancer-Associated Cachexia
    Xiaoting Sun, Xiaogang Feng, Xiaojing Wu, Yongtian Lu, Kaihong Chen, Ying Ye · 2020 · Frontiers in Cell and Developmental Biology
  82. Understanding the variegation of fat: Novel regulators of adipocyte differentiation and fat tissue biology
    Elisabetta Mueller · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  83. Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity
    Peishan Li, Yu Song, Wenying Zan, Liping Qin, Shuang Han, Baichun Jiang, Hao Dou, Changshun Shao, Yaoqin Gong · 2016 · Diabetes
  84. Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD
    Takeshi Inagaki · 2015 · Frontiers in Endocrinology
  85. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease
    De-wei Ye, Xianglu Rong, Aimin Xu, Jiao Guo · 2017 · Chinese Journal of Integrative Medicine
  86. Skeletal Muscle and Bone – Emerging Targets of Fibroblast Growth Factor-21
    Hui Sun, Matthew C. Sherrier, Hongshuai Li · 2021 · Frontiers in Physiology
  87. Sumoylation in gene regulation, human disease, and therapeutic action
    Xiang‐Jiao Yang, Cheng‐Ming Chiang · 2013 · F1000Prime Reports
  88. Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke
    Confidence Dordoe, Keyang Chen, Wenting Huang, Jun Chen, JIAN LI HU, Xue Bing Wang, Li Lin · 2021 · Frontiers in Pharmacology
  89. Suppression of Nrf2 attenuates adipogenesis and decreases FGF21 expression through PPAR gamma in 3T3-L1 cells
    Bo-Rahm Kim, Gha Young Lee, Hyeree Yu, Hyo Jin Maeng, Tae Jung Oh, Kyoung Min Kim, Jae Hoon Moon, Soo Kyung Lim, Hak Chul Jang, Sung Hee Choi · 2017 · Biochemical and Biophysical Research Communications
  90. Senp2 regulates adipose lipid storage by de-SUMOylation of Setdb1
    Quan Zheng, Ying Cao, Yalan Chen, Jiqiu Wang, Qiuju Fan, Xian Huang, Yiping Wang, Tianshi Wang, Xiuzhi Wang, Jiao Ma et al. · 2017 · Journal of Molecular Cell Biology
  91. The adipokine/ceramide axis: Key aspects of insulin sensitization
    Jonathan Y. Xia, Thomas S. Morley, Philipp E. Scherer · 2013 · Biochimie
  92. Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk
    Leigang Jin, Zhuofeng Lin, Aimin Xu · 2016 · Diabetes & Metabolism Journal
  93. Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
    Qing Li, Yuan Zhang, Ding Ding, Yunou Yang, Qian Chen, Dongfang Su, Xuechen Chen, Wenqi Yang, Jian Qiu, Wenhua Ling · 2016 · The Journal of Clinical Endocrinology & Metabolism
  94. SUMO proteins: Guardians of immune system
    Sabrina Adorisio, Alessandra Fierabracci, Isabella Muscari, Anna Marina Liberati, Emira Ayroldi, Graziella Migliorati, Trịnh Thị Thủy, Carlo Riccardi, Domenico Vittorio Delfino · 2017 · Journal of Autoimmunity
  95. Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPARγ
    Wenting Huang, Mingjie Shao, Huan Liu, Jun Chen, JIAN LI HU, Liyun Zhu, Fei Liu, Dongxue Wang, Yuchi Zou, Ye Xiong et al. · 2019 · Journal of Pharmacological Sciences
  96. FGF21 Takes a Fat Bite
    Carles Cantó, Johan H. Auwerx · 2012 · Science
  97. Novel insights into regulators and functional modulators of adipogenesis
    Hyun‐Yong Kim, Hyun‐Jun Jang, Subramanian Muthamil, Ung Cheol Shin, Ji‐Hyo Lyu, Seon-Wook Kim, Younghoon Go, Seong‐Hoon Park, Hee Gu Lee, Jun Hong Park · 2024 · Biomedicine & Pharmacotherapy
  98. Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE−/− mice
    Xi Wu, Yongfen Qi, Jin-Rui Chang, Weiwei Lu, Jin‐Sheng Zhang, Shaoping Wang, Shujuan Cheng, Ming Zhang, Qian Fan, Yuan Lv et al. · 2014 · Heart and Vessels
  99. The lipids
    Giovanni Mario Turchini, David Scott Francis, Zhen‐Yu Du, Rolf Erik Olsen, Einar Ringø, Douglas Redford Tocher · 2021 · Elsevier eBooks
  100. The regulation of FGF21 gene expression by metabolic factors and nutrients
    Anjeza Erickson, Régis F. Moreau · 2016 · Hormone Molecular Biology and Clinical Investigation